2006
DOI: 10.1080/00016480500469545
|View full text |Cite
|
Sign up to set email alerts
|

The prognostic value of proliferating cell nuclear antigen (PCNA) and p53 protein expression in patients with advanced nasopharyngeal carcinoma

Abstract: p53 nuclear staining was positive in 32 patients (69.6%). All cases had positive PCNA nuclear staining with labeling index (LI) ranging from 6.5% to 92.9% (mean 53.4%). Only advanced T stage was found to be associated with high PCNA LI. Overexpression of p53 and PCNA LI had no impact on 5-year survival in this study group.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
11
0

Year Published

2007
2007
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 23 publications
1
11
0
Order By: Relevance
“…In our study, PCNA expression of severely degenerated tumor cells was clearly inhibited by ALA-PDT, and the less damaged cells showed nearly the same expression level as control cells. PCNA is a cofactor for DNA polymerase ‰, which is required for DNA replication and cell proliferation (17). The surviving tumor cells with unchanged PCNA expression still have relative strong proliferation ability and may contribute to consequent tumor recurrence after ALA-PDT, as indicated by our study.…”
Section: Discussionsupporting
confidence: 54%
See 2 more Smart Citations
“…In our study, PCNA expression of severely degenerated tumor cells was clearly inhibited by ALA-PDT, and the less damaged cells showed nearly the same expression level as control cells. PCNA is a cofactor for DNA polymerase ‰, which is required for DNA replication and cell proliferation (17). The surviving tumor cells with unchanged PCNA expression still have relative strong proliferation ability and may contribute to consequent tumor recurrence after ALA-PDT, as indicated by our study.…”
Section: Discussionsupporting
confidence: 54%
“…PCNA is a 36-kDa nuclear polypeptide synthesized during the late G1 to S phase that acts as a homotrimer and helps increase the processivity of leadingstrand synthesis during DNA replication (16). PCNA is also a cofactor for DNA polymerase ‰, which is required for DNA replication and cell proliferation (17). Previous studies have demonstrated that a high level of PCNA expression is associated with poor prognosis in many solid tumors (17,18).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…RNAi, which is homologous to the gene being suppressed, is the sequence-specific, post-transcriptional gene silencing method caused by small interfering RNA duplexes (siRNAs) and is rapidly being established and holds promise to specifically inhibit gene expression in mammals (20). Based on establishing the CNE2sip53 cell line, which had stable expression of p53 shRNA in CNE2 cell line and satisfactory inhibition of the target p53 protein expression, the effects of persistent down-regulation of p53 gene expression on the transcriptional inactivation of the p53-responsive genes, and on cell proliferation, cell cycle, and the radiation sensitivity and apoptosis after ionizing radiation were demonstrated.…”
Section: Discussionmentioning
confidence: 99%
“…However, experimental evidence has confirmed that the overexpression of p53 seems to occur at an early stage in the development of NPC and associated with advanced disease stage, poor response to therapy. Overexpressed p53 protein is believed to have impaired tumor suppressor activity and to contribute to immortalization and cellular transformation (17,19,20). Until now, the activity of overexpressed p53 in the NPC remains unclear and the role of the p53 in NPC is RNA interference (RNAi) which is a sequence-specific and post-transcriptional gene silencing method initiated by doublestranded RNAs is increasingly being used to specifically inhibit gene expression in mammalian cells (21).…”
Section: Introductionmentioning
confidence: 99%